Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
World J Gastroenterol ; 23(40): 7337-7342, 2017 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-29142481

RESUMO

We report a case involving a rescued low birth weight infant (LBWI) with acute liver failure. CASE: The patient was 1594 g and 323/7 gestational wk at birth. At the age of 11 d, she developed acute liver failure due to gestational alloimmune liver disease. Exchange transfusion and high-dose gamma globulin therapy were initiated, and body weight increased with enteral nutrition. Exchange transfusion was performed a total of 33 times prior to living donor liver transplantation (LDLT). Her liver dysfunction could not be treated by medications alone. At 55 d old and a body weight of 2946 g, she underwent LDLT using an S2 monosegment graft from her mother. Three years have passed with no reports of intellectual disability or liver dysfunction. LBWIs with acute liver failure may be rescued by LDLT after body weight has increased to over 2500 g.


Assuntos
Hemocromatose/terapia , Recém-Nascido de Baixo Peso , Recém-Nascido Prematuro , Hipertensão Intra-Abdominal/terapia , Falência Hepática Aguda/terapia , Transplante de Fígado/efeitos adversos , Biópsia , Nutrição Enteral , Transfusão Total , Feminino , Rejeição de Enxerto/tratamento farmacológico , Hemocromatose/sangue , Hemocromatose/complicações , Humanos , Terapia de Imunossupressão/métodos , Lactente , Recém-Nascido , Hipertensão Intra-Abdominal/etiologia , Fígado/patologia , Fígado/cirurgia , Falência Hepática Aguda/sangue , Falência Hepática Aguda/etiologia , Falência Hepática Aguda/patologia , Transplante de Fígado/métodos , Doadores Vivos , Insuficiência Respiratória/etiologia , Insuficiência Respiratória/terapia , Resultado do Tratamento , gama-Globulinas/uso terapêutico
2.
Circ J ; 80(11): 2388-2396, 2016 Oct 25.
Artigo em Inglês | MEDLINE | ID: mdl-27666597

RESUMO

BACKGROUND: Extremely preterm infants frequently have patent ductus arteriosus (PDA). Recent recommendations include immediately beginning amino acid supplementation in extremely preterm infants. However, the effect of amino acids on closure of the ductus arteriosus (DA) remains unknown.Methods and Results:Aminogram results in human neonates at day 2 revealed that the plasma glutamate concentration was significantly lower in extremely preterm infants (<28 weeks' gestation) with PDA than in those without PDA and relatively mature preterm infants (28-29 weeks gestation). To investigate the effect of glutamate on DA closure, glutamate receptor expression in fetal rats was examined and it was found that the glutamate inotropic receptor, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) type subunit 1 (GluR1), mRNA was highly expressed in the DA compared to the aorta on gestational day 19 (preterm) and gestational day 21 (term). GluR1 proteins were co-localized with tyrosine hydroxylase-positive autonomic nerve terminals in the rat and human DA. Intraperitoneal administration of glutamate increased noradrenaline production in the rat DA. A whole-body freezing method demonstrated that glutamate administration induced DA contraction in both preterm (gestational day 20) and term rat fetuses. Glutamate-induced DA contraction was attenuated by the calcium-sensitive GluR receptor antagonist, NASPM, or the adrenergic receptor α1 blocker, prazosin. CONCLUSIONS: These data suggest that glutamate induces DA contraction through GluR-mediated noradrenaline production. Supplementation of glutamate might help to prevent PDA in extremely preterm infants. (Circ J 2016; 80: 2388-2396).


Assuntos
Canal Arterial/fisiologia , Ácido Glutâmico/farmacologia , Contração Miocárdica/efeitos dos fármacos , Norepinefrina/biossíntese , Receptores de AMPA/metabolismo , Animais , Humanos , Recém-Nascido , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA